California Rezulin Injury Lawyers

Marketed by Warner-Lambert and Parke-Davis to treat Type II Diabetes Mellitus, Rezulin was pulled from the market on March 21, 2000. Over the months leading up to its recall, there was considerable medical press about damage to the liver that was occurring. The manufacturers had tried to keep the drug on the market by including ever increasing warnings about this risk, but the only proper solution was withdrawal, especially since there are other drugs on the market affording the same treatment more safely. The specific type of damage, which is part of the lawsuits around the country, is cirrhosis of the liver. This has led to, on occasion, the need for liver transplant, or worse, to death. At the time of its withdrawal from the market, it was estimated that 500,000 people were currently on Rezulin. The drug has been linked to 90 confirmed reports of liver failure, including 60 deaths. Rezulin generated over $1.8 billion in sales. If you, or anyone you know, have suffered problems while using Rezulin, you should contact one of our dangerous drug attorneys immediately to investigate your right to file suit against the manufacturer of this drug.

Back to Pharmaceutical Litigation.